Cancers such as T-cell acute lymphoblastic leukemia (T-ALL), cutaneous T-cell lymphoma (CTCL), and its leukemic variant, Sézary Syndrome, revealed constitutive NFκB activity1, 2, 3, 4. This evidence concerns the gene NFKB1 and T-cell acute lymphoblastic leukemia.